Sign Up
Stories
CCM Biosciences Launches 5Prime Sciences
Share
Biotech Collaboration Enhances Industry ...
Biotech Innovations and Financing
Biotech Updates and Market Projections
4DMT Presents Positive Interim Data
Biotech Collaboration Enhances CRISPR In...
Biotech Collaboration Enhances Sector So...
Overview
API
CCM Biosciences launches 5Prime Sciences business unit focusing on DNA biotechnology and molecular diagnostics, leveraging patented technology for overcoming sequence bias in IVD tests and synthetic biology.
Ask a question
How might the development of proprietary technology for IVD tests impact the diagnostics industry?
What are the ethical considerations associated with the use of patented technology in the development of diagnostic methods and synthetic biology?
What potential applications could synthetic biology have in various fields, and how might this impact the market?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Sep 2023
Oct 2023
Nov 2023
Coverage